SELLAS Life Sciences Group Investor Relations Material
Latest events
Study Update
SELLAS Life Sciences Group
Q1 2025
13 May, 2025
Q4 2024
20 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from SELLAS Life Sciences Group Inc
Access all reports
SELLAS Life Sciences Group Inc. is a biopharmaceutical company focused on developing immunotherapies for cancer. The company specializes in targeted peptide-based therapies designed to stimulate the immune system against various tumor types. Its research and development efforts aim to advance novel cancer treatments through clinical trials and regulatory approvals. The company is headquartered in Montvale, New Jersey, and its shares are listed on the NASDAQ.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
SLS
Country
🇺🇸 United States